Literature DB >> 25857722

Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals.

S F Issa1, A F Christensen2, T Lottenburger2, K Junker3, H Lindegaard1, K Hørslev-Petersen4, P Junker1.   

Abstract

Galectin-3 has been suggested as a pro-inflammatory mediator in rheumatoid arthritis (RA). Previous studies have reported overexpression of Galectin-3 in RA synovitis and increased levels in synovial fluid and serum in long-standing RA compared with osteoarthritis and healthy controls. Our objectives were to study whether serum Galectin-3 (1) exhibits circadian variation and/or (2) responds to exercise in RA and controls. The study on circadian patterns (1) comprised eleven patients with newly diagnosed RA, disease duration less than 6 months (ERA), 10 patients with long-standing RA [5-15 years (LRA)] and 16 self-reportedly healthy control subjects. During 24 h, 7 blood samples were drawn at 3-h intervals starting at 10 a.m. through 10 p.m. and at 7 and 10 a.m. on the following day. The study on the effect of physical activity (2) included 10 patients with ERA, 10 with LRA and 14 controls. The participants underwent a standardized exercise programme and four blood samples were drawn before, during and after exercise. Serum Galectin-3 was quantified by ELISA (R&amp;D systems). (1) Galectin-3 was increased at baseline in both RA subsets (P = 0.08). There were no diurnal oscillations (P = 0.85). Day-to-day variation amounted to 3%. (2) Baseline Galectin-3 was increased in LRA versus controls and ERA (P < 0.01 and 0.05). Physical exercise induced 10-15% Galectin-3 increments in RA and controls (P < 0.001) peaking after 1-3 h. To conclude, Galectin-3 did not exhibit circadian variation. Day-to-day variation was 3%. Exercise elicited comparable increments in patients with RA of short and long duration and controls, approaching normal after 1-3 h.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25857722     DOI: 10.1111/sji.12301

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation.

Authors:  Kosuke Kajitani; Kazuyuki Yanagimoto; Yusaku Nakabeppu
Journal:  Psychopharmacology (Berl)       Date:  2017-07-11       Impact factor: 4.530

2.  Predictive Value of Galectin-3 and Brachial-Ankle Pulse Wave Velocity for Coronary Artery Calcification in Coronary Arteriography Patients.

Authors:  Lei Tian; Fenghua Ding; Ruiyan Zhang
Journal:  Int J Clin Pract       Date:  2022-05-16       Impact factor: 3.149

Review 3.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

4.  Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage.

Authors:  Hua Liu; Yong Liu; Jinbing Zhao; Hongyi Liu; Shengxue He
Journal:  Brain Behav       Date:  2016-08-02       Impact factor: 2.708

5.  Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes.

Authors:  Brian J Andonian; David B Bartlett; Janet L Huebner; Leslie Willis; Andrew Hoselton; Virginia B Kraus; William E Kraus; Kim M Huffman
Journal:  Arthritis Res Ther       Date:  2018-12-27       Impact factor: 5.156

6.  Serum galectin-3 levels are decreased in schizophrenia.

Authors:  Faruk Kiliç; Ümit Işik; Arif Demirdaş; Ayşe Usta
Journal:  Braz J Psychiatry       Date:  2020-03-09       Impact factor: 2.697

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.